Wang J, Zhu XN, Zhu LL, Chen W, Ma YH, Gan T, Yang JL. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions. World J Gastroenterol 2018; 24(26): 2878-2885 [PMID: 30018482 DOI: 10.3748/wjg.v24.i26.2878]
Corresponding Author of This Article
Jin-Lin Yang, MD, PhD, Chief Doctor, Doctor, MHSc, Professor, Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, 37th Guoxue Alley, Chengdu 610041, Sichuan Province, China. mouse-577@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 14, 2018; 24(26): 2878-2885 Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2878
Table 1 Baseline characteristics of 311 lesions treated with endoscopic submucosal tunnel dissection n (%)
Category
ESTD (n = 311)
Sex, male/female
213/98
Age, yr, mean (range)
61.4 ± 8.1 (40-83)
Tumor location
Upper third
24 (7.72)
Middle third
200 (64.31)
Lower third
87 (27.97)
Paris classification
0-I
18 (5.79)
0-IIa
111 (35.69)
0-IIb
94 (30.23)
0-IIc
35 (11.25)
0-IIa-IIc
50 (16.08)
0-III
3 (0.96)
Circumferential level
≤ 1/4
11 (3.54)
≤ 1/2
163 (52.41)
≤ 3/4
65 (20.90)
≤ 7/8
41 (13.18)
≤ 1
31 (9.97)
Table 2 Pre-endoscopic submucosal tunnel dissection and post-endoscopic submucosal tunnel dissection pathology n (%)
Pathology
Pre-ESTD
Post-ESTD
Pre-ESTD and Post-ESTD coincidence
Inflammation
0
3 (0.96)
0
LGIN
67 (21.54)
43 (13.83)
36 (11.57)
HGIN
159 (51.13)
52 (16.72)
37 (11.90)
M1
74 (23.79)
74 (23.79)
18 (5.79)
M2
11 (3.54)
47 (15.11)
3 (0.96)
M3
0
51 (16.40)
0
SM1
0
23 (7.40)
0
> SM1
0
18 (5.79)
0
Table 3 Endoscopic submucosal tunnel dissection procedure characteristics n (%)
Category
ESTD (n = 311)
Specimen area, cm2, mean ± SD
14.1 ± 3.6
Tumor width diameter, cm, mean ± SD
3.1 ± 0.6
Tumor length diameter, cm, mean ± SD
4.2 ± 0.9
Procedure time, min, mean ± SD
102.4 ± 35.3
Dissection speed, mm2/ min, mean ± SD
18.6 ± 2.1
En bloc resection
308 (99.04)
R0 resection
259 (81.28)
Curative resection
244 (78.46)
Hospitalization day, d, mean ± SD
10.3 ± 2.8
Hospitalization expense, dollars, mean ± SD
3766.5 ± 846.5
Table 4 Endoscopic submucosal tunnel dissection-related complications n (%)
Category
ESTD (n = 311)
Post-operative infection
30 (9.65)
Bleeding
Intraoperative bleeding
20 (6.43)
Postoperative bleeding
5 (1.61)
Muscular injury
98 (31.51)
Perforation
6 (1.93)
Esophageal stricture
46 (14.79)
Positive margin
Horizontal margin
35 (11.25)
Vertical margin
10 (3.22)
Horizontal and vertical margin
4 (1.29)
Lymphovascular invasion
12 (3.86)
Citation: Wang J, Zhu XN, Zhu LL, Chen W, Ma YH, Gan T, Yang JL. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions. World J Gastroenterol 2018; 24(26): 2878-2885